Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pavese, N.
Right arrow Articles by Piccini, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pavese, N.
Right arrow Articles by Piccini, P.
Related Collections
Right arrow PET
Right arrow Parkinson's disease/Parkinsonism
NEUROLOGY 2006;67:1612-1617
© 2006 American Academy of Neurology

Clinical correlates of levodopa-induced dopamine release in Parkinson disease

A PET study

N. Pavese, MD, A. H. Evans, MD, Y. F. Tai, MRCP, G. Hotton, MRCP, D. J. Brooks, MD, DSc, A. J. Lees, MD, FRCP and P. Piccini, MD, PhD

From the MRC Clinical Sciences Centre and Division of Neurosciences (N.P., Y.F.T., G.H., D.J.B., P.P.), Faculty of Medicine, Imperial College, Hammersmith Hospital, and Reta Lila Weston Institute of Neurological Studies and the National Hospital for Neurology and Neurosurgery (A.H.E., A.J.L.), London, UK.

Address correspondence and reprint requests to Dr. P. Piccini, MRC Clinical Sciences Centre and Division of Neurosciences, Faculty of Medicine, Imperial College, Hammersmith Hospital, Du Cane Road, London W12 ONN, UK; e-mail: paola.piccini{at}csc.mrc.ac.uk

Objective: To evaluate the relationship between clinical improvement and in vivo synaptic dopamine (DA) release after a single oral dose of levodopa (LD) in patients with advanced Parkinson disease (PD).

Methods: We studied 16 patients with advanced PD with [11C]raclopride (RAC) PET. Each patient had RAC PET twice: once when medication had been withdrawn and once after an LD challenge. On the day of the LD challenge scan, oral 250 mg LD/25 mg carbidopa was given before scanning. Unified Parkinson's Disease Rating Scale (UPDRS) motor scores were rated in an "off" state before LD and again at the end of PET.

Results: All the patients were still in "on" state at the end of their LD challenge RAC PET scans. Following LD, mean caudate and putamen RAC binding potentials (BPs) were significantly lower vs baseline, consistent with increased synaptic DA. Individual LD-induced improvements in UPDRS score correlated significantly with reductions in putaminal BP. Additionally, large putaminal RAC BP changes were associated with higher dyskinesia scores. When motor UPDRS subitems were examined, improvements in rigidity and bradykinesia, but not in tremor or axial symptoms, correlated with putamen DA release.

Conclusion: In advanced Parkinson disease, the improvement of rigidity and bradykinesia and the presence of dyskinesias after a single dose of oral levodopa are governed by the level of dopamine generated at striatal D2 receptors. In contrast, relief of parkinsonian tremor and axial symptoms is not related to striatal synaptic dopamine levels and presumably occurs via extrastriatal mechanisms.


Disclosure: The authors report no conflicts of interest.

Received February 28, 2006. Accepted in final form June 27, 2006.




This article has been cited by other articles:


Home page
BrainHome page
M. Karimi, N. Golchin, S. D. Tabbal, T. Hershey, T. O. Videen, J. Wu, J. W. M. Usche, F. J. Revilla, J. M. Hartlein, A. R. Wernle, et al.
Subthalamic nucleus stimulation-induced regional blood flow responses correlate with improvement of motor signs in Parkinson disease
Brain, August 12, 2008; (2008) awn179v1.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. Lee, W.-M. Zhu, D. Stanic, D. I. Finkelstein, M. H. Horne, J. Henderson, A. J. Lawrence, L. O'Connor, D. Tomas, J. Drago, et al.
Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia
Brain, June 1, 2008; 131(6): 1574 - 1587.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. J. Kish, J. Tong, O. Hornykiewicz, A. Rajput, L.-J. Chang, M. Guttman, and Y. Furukawa
Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease
Brain, January 1, 2008; 131(1): 120 - 131.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by AAN Enterprises, Inc.